CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in ALGERT GLOBAL LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2025 Q2)
Avg. % of fund
0.04%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 112,220 -266,151 -70.3% 0.04% $2.2M $19.70
2025 Q2 ADDED 378,371 +329,981 +681.9% 0.17% $8.2M $21.70
2025 Q1 ADDED 48,390 +470 +1.0% 0.03% $1.2M $24.25
2024 Q4 ADDED 47,920 +31,115 +185.2% 0.02% $1.0M $20.87
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CPRX price (monthly, adj. close)

Other funds also holding CPRX

As of 2025 Q4 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to ALGERT GLOBAL LLC Holdings